Drug makers struggle to create key products of 10 billion won sales.

Leading domestic pharmaceutical firms are trying to create their key products at the level of 10 billion won sales in order to generate their stable revenue and income, after fully realizing that the company hardly overcome the protracted pharmaceutical economic recession and achieve sales targets without them.

The key items by company are illustrated as follows:

Dong-A targeted key pre...